Risk Adjustment in Health Insurance Markets
Do Not Overlook the “Real” Healthy
Bibliographic Data
| ID | 9100276 |
|---|---|
| Authors | Richard C van Kleef (0000-0002-8971-6341, Center for Personalized Cancer Treatment, corresponding author), René C J A Van Vliet (Erasmus University Rotterdam), Michel Oskam (0000-0003-0052-785X, Erasmus University Rotterdam) |
| Year | 2024 |
| Volume | 62 |
| Issue | 11 |
| Pages | 767-772 |
| Publication date | 2024-11-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/mlr.0000000000001955 |
| PMID | 38047754 |
| OpenAlex | W4389298676 |
| Language | EN |
| References cited | 21 |
OBJECTIVES: The goals of this paper are: (1) to identify groups of healthy people; and (2) to quantify the extent to which the Dutch risk adjustment (RA) model overpays insurers for these groups. BACKGROUND: There have been strong signals that insurers in the Dutch regulated health insurance market engage in actions to attract healthy people. A potential explanation for this behavior is that the Dutch RA model overpays insurers for healthy people. METHODS: We identify healthy groups using 3 types of ex-ante information (ie, information available before the start of the health insurance contract): administrative data on prior spending for specific health care services (N = 17 m), diagnoses from electronic patient records (N = 1.3 m), and health survey data (N = 457 k). In a second step, we calculate the under/overpayment for these groups under the Dutch RA model (version: 2021). RESULTS: We distinguish eight groups of healthy people using various "identifiers." Although the Dutch RA model substantially reduces the predictable profits that insurers face for these groups, significant profits remain. The mean per person overpayment ranges from 38 euros (people with hospital spending below the third quartile in each of 3 prior years) to 167 euros (those without any medical condition according to their electronic patient record). CONCLUSIONS: The Dutch RA model does not eliminate the profitability of healthy groups. The identifiers used for flagging these groups, however, seem inappropriate for serving as risk adjuster variables. An alternative way of exploiting these identifiers and eliminating the profitability of healthy groups is to estimate RA models with "constrained regression."
Actuarial science · Business · Economics · Euros · Flagging · Health care · Health insurance · Identifier · Medical diagnosis · Profitability index · Quartile · Chronic Disease Management Strategies · Computer Science · Finance · Healthcare Policy and Management · Healthcare Systems and Reforms · Medicine
Do health insurers use target marketing as a tool for risk selection? Evidence from the Netherlands
Prior Use of Durable Medical Equipment as a Risk Adjuster for Health-Based Capitation
Health-Based Risk Adjustment
Upcoding
Improving Risk Equalization Using Multiple-year High Cost as a Health Indicator
Clinical Risk Groups (CRGs)
Selection in Insurance Markets
| Highly cited | No |
|---|